from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2782c/pepR

LFCtreatmentdescriptionclass of inhibitor

-0.547

Amikacinug/mL Amikacintranslation

-1.604

Cap5-10ug/mL Capreomycintranslation

-0.990

Rox10-50 ug/mL Roxithromycintranslation

0.328

SM2-5 ug/mL Streptomycintranslation

0.691

Tet5-10 ug/mL Tetracyclinetranslation

1.120

Rif0.2-5ug/mL Rifampicintranscription

0.435

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.233

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.186

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.860

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.016

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.706

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.009

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.235

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.155

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.417

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.118

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.859

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.995

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.157

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.051

KCN5-20 ug/mL Potassium cyaniderespiration

0.881

NaN30.2-2 mM Sodium aziderespiration

-0.301

Nigericin50 uM Nigericinrespiration

-0.302

TRC10-150 ug/mL Triclosanrespiration

-0.953

TRZ10-25 ug/mL Thioridazinerespiration

-0.915

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.110

menadione6-10 ug/mL Menadionerespiration

0.114

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.186

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.190

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.280

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.963

NRP_1Non-replicating persistence stage 1dosRassociated

0.324

Amp0.2mg/mL AmpicillincellWall

0.389

Cephalexin20-100 ug/mL CephalexincellWall

-0.428

Cerulenin0.32-5 ug/mL CerulenincellWall

0.308

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.065

EMB10-20 ug/mL EthambutolcellWall

0.200

Eta12-40 ug/mL EthionamidecellWall

0.408

INH0.2-0.4 ug/mL IsoniazidcellWall

0.096

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.167

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.411

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.553

BZA0.12 mg/mL BenzamidearomaticAmides

0.781

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.713

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.198

H2O24 mM hydrogen peroxideDNAdamaging

0.204

Levo10 ug/mL LevofloxacinDNAdamaging

0.426

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.260

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.027

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.107

UVUV-irradiationDNAdamaging

-1.497

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.110

Antimycin12.5-50 ug/mL Antimycin A?

-0.123

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.340

PA_110-50 ug/mL Antitubercular compound PA-1?

0.506

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.229

PA8240.2-2 ug/mL PA-824?

1.032

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.962

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.457

Verapamil50 uM Verapamil?

-0.414

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.591

methoxatin10-20 ug/mL Methoxatin?